1. Home
  2. PDEX vs TNXP Comparison

PDEX vs TNXP Comparison

Compare PDEX & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pro-Dex Inc.

PDEX

Pro-Dex Inc.

HOLD

Current Price

$72.89

Market Cap

197.4M

Sector

Health Care

ML Signal

HOLD

Logo Tonix Pharmaceuticals Holding Corp.

TNXP

Tonix Pharmaceuticals Holding Corp.

HOLD

Current Price

$10.88

Market Cap

199.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDEX
TNXP
Founded
1978
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
197.4M
199.7M
IPO Year
1995
2008

Fundamental Metrics

Financial Performance
Metric
PDEX
TNXP
Price
$72.89
$10.88
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$56.00
N/A
AVG Volume (30 Days)
62.5K
413.4K
Earning Date
05-01-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
54.31
91.75
EPS
4.12
N/A
Revenue
$77,548,000.00
$13,107,000.00
Revenue This Year
$7.22
$558.11
Revenue Next Year
N/A
$38.29
P/E Ratio
$17.60
N/A
Revenue Growth
16.45
29.85
52 Week Low
$23.52
$9.40
52 Week High
$77.00
$25.69

Technical Indicators

Market Signals
Indicator
PDEX
TNXP
Relative Strength Index (RSI) 60.59 33.24
Support Level $56.35 $10.03
Resistance Level $77.00 $12.99
Average True Range (ATR) 4.29 0.55
MACD 0.90 -0.28
Stochastic Oscillator 78.30 10.01

Price Performance

Historical Comparison
PDEX
TNXP

About PDEX Pro-Dex Inc.

Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Its portfolio consists of commercial, development and discovery-stage programs, TONMYA, an approved treatment for fibromyalgia, as well as marketed acute migraine products Zembrace SymTouch and Tosymra. The company is conducting clinical trials to evaluate TONMYA for additional indications such as depressive disorder and acute stress disorder. It is also advancing a pipeline of immunology programs, including monoclonal antibody TNX-4800 for Lyme disease prophylaxis and TNX-1500, a third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection.

Share on Social Networks: